These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 15202388)

  • 21. Drugs and alcohol: patient information.
    Blackburn JL; Hawes EM
    Can J Hosp Pharm; 1977; 30(3):73-5, 87. PubMed ID: 10304735
    [No Abstract]   [Full Text] [Related]  

  • 22. [Generic preparations--undocumented effects?].
    Dyrkorn R
    Tidsskr Nor Laegeforen; 2006 Oct; 126(19):2548; author reply 2548. PubMed ID: 17028644
    [No Abstract]   [Full Text] [Related]  

  • 23. [Generic preparations--undocumented effects?].
    Høiseth A
    Tidsskr Nor Laegeforen; 2006 Nov; 126(22):2985-6; author reply 2986. PubMed ID: 17117201
    [No Abstract]   [Full Text] [Related]  

  • 24. [Drug committees should not recommend "off label" prescriptions].
    Rane A
    Lakartidningen; 2006 Apr 12-25; 103(15-16):1219. PubMed ID: 16696203
    [No Abstract]   [Full Text] [Related]  

  • 25. [Equivalent preparations--equivalent package inserts?].
    Talseth T
    Tidsskr Nor Laegeforen; 2008 Sep; 128(17):1985-6. PubMed ID: 18787578
    [No Abstract]   [Full Text] [Related]  

  • 26. Drug-name game.
    Consum Rep; 2006 Jan; 71(1):9. PubMed ID: 16491526
    [No Abstract]   [Full Text] [Related]  

  • 27. [Reliable generic prescription wanted].
    Rønhof KM
    Ugeskr Laeger; 2007 Nov; 169(48):4185; author reply 4186. PubMed ID: 18213934
    [No Abstract]   [Full Text] [Related]  

  • 28. Authorized generic drugs, price competition, and consumers' welfare.
    Berndt ER; Mortimer R; Bhattacharjya A; Parece A; Tuttle E
    Health Aff (Millwood); 2007; 26(3):790-9. PubMed ID: 17485758
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enforcement related to off-label marketing and use of drugs and devices: where have we been and where are we going?
    Joseph JN; Deaton D; Ehsan H; Bonanno MA
    J Health Life Sci Law; 2009 Jan; 2(2):73-108. PubMed ID: 19288889
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Generics market in Greece: the pharmaceutical industry's beliefs.
    Geitona M; Zavras D; Hatzikou M; Kyriopoulos J
    Health Policy; 2006 Nov; 79(1):35-48. PubMed ID: 16386326
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Drug coupons don't always save money.
    Consum Rep; 2009 Feb; 74(2):13. PubMed ID: 19306503
    [No Abstract]   [Full Text] [Related]  

  • 32. FDA approves generic AZT for U.S. market.
    O'Rourke M
    AIDS Clin Care; 2005 Nov; 17(11):108. PubMed ID: 16323302
    [No Abstract]   [Full Text] [Related]  

  • 33. [The Medical Products Agency and testosterone treatment. Act II].
    Lindholm J
    Ugeskr Laeger; 2005 May; 167(20):2200; author reply 2200. PubMed ID: 15987085
    [No Abstract]   [Full Text] [Related]  

  • 34. [The Medical Products Agency and testosterone treatment. The 3rd and the last act].
    Lindholm J
    Ugeskr Laeger; 2005 Aug; 167(33):3072-4. PubMed ID: 16109265
    [No Abstract]   [Full Text] [Related]  

  • 35. Drug marketing exclusivity under United States and European Union law.
    Junod V
    Food Drug Law J; 2004; 59(4):479-518. PubMed ID: 15875347
    [No Abstract]   [Full Text] [Related]  

  • 36. Attitudes of Slovene general practitioners towards generic drug prescribing and comparison with international studies.
    Kersnik J; Peklar J
    J Clin Pharm Ther; 2006 Dec; 31(6):577-83. PubMed ID: 17176362
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Counterfeit and substandard antimalarial drugs in Cambodia.
    Lon CT; Tsuyuoka R; Phanouvong S; Nivanna N; Socheat D; Sokhan C; Blum N; Christophel EM; Smine A
    Trans R Soc Trop Med Hyg; 2006 Nov; 100(11):1019-24. PubMed ID: 16765399
    [TBL] [Abstract][Full Text] [Related]  

  • 38. By any other name: ambiguity in marketing proprietary anti-infective agents.
    Berger SA
    Clin Infect Dis; 2007 Jan; 44(1):65-8. PubMed ID: 17143817
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [More information on drug package inserts and counseling replace the warning triangle].
    Beermann B; Liliemark J; Johansson K
    Lakartidningen; 2005 Jun 13-26; 102(24-25):1918, 1921. PubMed ID: 16044776
    [No Abstract]   [Full Text] [Related]  

  • 40. White paper. The five myths of generic competition. A Pharma Matters report. March 2009.
    Drug News Perspect; 2009 Apr; 22(3):171-5. PubMed ID: 19440560
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.